Insider cluster is too small to draw a directional signal. Monitor for any material insider buying from C-suite or larger positions in future filings.
KROS drugs
KROS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 18 $10.65entry
- T+1 · 5mo ago +3.10%α +3.41% · $10.98
- T+5 · 5mo ago −2.25%α −0.59% · $10.41
- T+20 · 4mo ago −0.38%α −0.91% · $10.61
- T+60 · 2mo ago +5.26%α +3.36% · $11.21
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two KROS directors made minor opposing trades: Bienaime purchased $10K worth of shares while Newton sold $6K. Total insider activity is $16K, less than 0.01% of the $199M market cap, trivial and lacking a clear directional signal.
Key Financial Metrics
Key Facts
- Director Jean Jacques Bienaime purchased 1,000 shares at $10.19 for $10,190 on 2026-06-15.
- Director Charles W. Newton sold 550 shares at $10.04 for $5,522 on 2026-06-11.
- Total value of trades is ~$16K, representing ~0.008% of KROS's $199M market cap.
- Both trades are open-market; no C-suite involvement.
Financial Impact
Trivial insider activity, total $16K across 2 directors, <0.01% of market cap. No material economic signal.
Risk Factors
- Small sample, only 2 trades.
- Directors may not be as informed about near-term catalysts as C-suite executives.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-KROS-1781729786258 |
Track record
27 reports on KROS
4 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +12.51% at T+60 after the Jul 30, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 16, 2026today Press Release Neutral 2/10 Entry $10.03 Now $10.03 −0.00% settles Dec 16
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $10.30 Now $10.03 −2.62% settles Dec 14
- Nov 5, 202611d ago 8-K Neutral 3/10 Entry $9.36 Now $10.03 +7.16% settles Dec 7
- Nov 5, 202611d ago 8-K Neutral 5/10 Entry $9.36 Now $10.03 +7.16% settles Dec 7
- Nov 5, 202611d ago Press Release Neutral 5/10 No price data
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $11.61 Now $10.03 −13.61% settles Nov 25
- Sep 29, 20266w ago 8-K Bullish 6/10 Entry $11.19 to $11.43 Now $10.03 −10.37% ▲ +2.10% +1.39% vs SPY
- Sep 28, 20267w ago 8-K Neutral 4/10 Entry $11.28 to $11.33 Now $10.03 −11.08% ▲ +0.44% +0.47% vs SPY
- Sep 28, 20267w ago Press Release Neutral 3/10 Entry $11.28 to $11.33 Now $10.03 −11.08% ▲ +0.44% +0.47% vs SPY
- Sep 17, 20268w ago EFFECT Neutral 3/10 Entry $11.36 to $11.10 Now $10.03 −11.71% ▼ −2.29% −3.49% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers